Further evaluation of diethyldithiocarbamate as an antagonist of cisplatin toxicity.
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002945:Cisplatin / Q000037:antagonists & inhibitors / Q000627:therapeutic use / Q000633:toxicity*; D004050:Ditiocarb / Q000494:pharmacology / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D007683:Kidney Tubular Necrosis, Acute / Q000139:chemically induced / Q000473:pathology; D007939:Leukemia L1210 / Q000188:drug therapy / Q000401:mortality; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D009929:Organ Size / Q000187:drug effects; D011041:Poisoning / Q000188:drug therapy* / Q000401:mortality; D051381:Rats; D011916:Rats, Inbred F344; D013270:Stomach / Q000033:anatomy & histology / Q000187:drug effects; D013859:Thiocarbamates / Q000627:therapeutic use*
D013859:Thiocarbamates; D004050:Ditiocarb; D002945:Cisplatin